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Abstract
Background
Additional healthcare visits and rehospitalizations after discharge are frequent among
patients with community-acquired pneumonia (CAP) and have a major impact on health-
care costs. We aimed to determine whether the implementation of an individualized educa-
tional program for hospitalized patients with CAP would decrease subsequent healthcare
visits and readmissions within 30 days of hospital discharge.
Methods
Amulticenter, randomized trial was conducted from January 1, 2011 to October 31, 2014
at three hospitals in Spain. We randomly allocated immunocompetent adults patients hospi-
talized for CAP to receive either an individualized educational program or conventional
information before discharge. The educational program included recommendations regard-
ing fluid intake, adherence to drug therapy and preventive vaccines, knowledge and man-
agement of the disease, progressive adaptive physical activity, and counseling for alcohol
and smoking cessation. The primary trial endpoint was a composite of the frequency of
additional healthcare visits and rehospitalizations within 30 days of hospital discharge.
Intention-to-treat analysis was performed.
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Results
We assigned 102 patients to receive the individualized educational program and 105 to
receive conventional information. The frequency of the composite primary end point was
23.5% following the individualized program and 42.9% following the conventional informa-
tion (difference, -19.4%; 95% confidence interval, -6.5% to -31.2%; P = 0.003).
Conclusions
The implementation of an individualized educational program for hospitalized patients with
CAP was effective in reducing subsequent healthcare visits and rehospitalizations within 30
days of discharge. Such a strategy may help optimize available healthcare resources and
identify post-acute care needs in patients with CAP.
Trial Registration
Controlled-Trials.com ISRCTN39531840
Introduction
Community-acquired pneumonia (CAP) is a major cause of death and has the highest mortal-
ity of all infectious diseases in industrialized countries [1]. In addition, CAP accounts for more
than 1 million hospitalizations annually, costing the United States more than $9.7 billion [2];
in Europe, pneumonia costs €10.1 billion annually, with inpatient care costing €5.7 billion, out-
patient care costing €0.5 billion, and medication costing €0.2 billion [3]. Currently, 30%-60%
of patients diagnosed with CAP are admitted to hospital and the high cost of treating CAP has
raised interest in the development of strategies to reduce the length of hospitalization and
increase the number of patients who receive care at home [4,5].
Recent studies have found that additional healthcare interactions within 30 days of dis-
charge are common among patients with CAP [6,7], occurring at rates of 7% to 34% [6–9]. The
risk factors associated with additional healthcare visits and rehospitalizations typically include
comorbid diseases (mainly cardiopulmonary disease), lack of proper information before dis-
charge, and lifestyle factors (mainly unemployment, low level education, and smoking and
alcohol abuse) [6,7,9,10].
In an era of increasing competition for economic resources in medical care, institutions
have an interest in developing new tools to decrease healthcare resources consumption and to
improve healthcare quality [3,11,12]. Discharge planning has been associated with improved
use of post-discharge services and fewer readmissions, and appears to prepare patients and
caregivers for post-discharge care [13]. Interestingly, it can be hypothesized that some health-
care interactions might be preventable by adequately educating patients before discharge.
However, few studies have examined the effect of educational interventions in patients with
CAP [14–16]. Moreover, those that have been performed conclude that discharge planning
effectively improved patient knowledge, increased cost-effective use of inpatient beds, and
improved patient satisfaction with their care [14–17]. Nevertheless, no trials have examined
the effects of educational programs to decrease additional healthcare visits and rehospitaliza-
tions after discharge in patients with CAP.
We designed a randomized controlled trial (EDUCAP) to test the hypothesis that imple-
menting an individualized educational program for hospitalized patients with CAP would
The EDUCAP Randomized Controlled Trial
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decrease subsequent healthcare interactions after hospital discharge. The primary endpoint of
the trial was defined as the frequency of the composite outcome of additional healthcare visits
and rehospitalizations within 30 days of hospital discharge.
Materials and Methods
Design and Patients
The EDUCAP randomized trial was conducted at three university hospitals in Catalonia,
Spain, between January 1, 2011, and October 31, 2014. The participating hospitals were: the
Bellvitge Institute for Biomedical Research (IDIBELL)–Hospital Universitari de Bellvitge–a
700-bed university public hospital; the August Pi i Sunyer Biomedical Research Institute
(IDIBAPS)–Hospital Clínic de Barcelona–an 800-bed university public hospital; and the Bio-
medical Research Institute of Lleida (IRBLleida)–Hospital Universitari Arnau de Vilanova–a
400-bed university public hospital. Written informed consent was obtained from patients or
relatives provided in accordance with the Declaration of Helsinki. This study was approved by
the institutional review board Ethics Committee of Hospital Universitari de Bellvitge (PR183/
09), Hospital Clínic de Barcelona (2010/6145) and Hospital Universitari Arnau de Vilanova
(1261).
All immunocompetent patients aged 18 years or older and diagnosed with CAP in the par-
ticipating hospitals were screened for eligibility at the study onset. CAP was defined as the pres-
ence of an infiltrate on chest radiograph plus one or more of the following: fever (temperature,
 38.0°C) or hypothermia (< 35.0°C), new cough with or without sputum production, pleu-
ritic chest pain, dyspnea, and altered breath sounds on auscultation. Patients from nursing
homes or long-term care facilities were excluded, as were patients with neutropenia (<500/μL),
immunoglobulin deficiencies, HIV infection, those who had undergone transplantation or
splenectomy, and those who were receiving immunosuppressant and/or corticosteroid therapy
(>20 mg/day of prednisone or equivalent). Furthermore, patients with cognitive deficits or
those who did not understand Spanish or Catalan were excluded.
Randomization
We randomly allocated patients to receive either an individualized educational program or
conventional information before discharge. Randomization was performed in computer-gener-
ated blocks of ten and stratified by participating hospital; the randomization code was kept by
the epidemiologist in a sealed envelope. Either in the emergency department or during hospi-
talization, patients who met the study criteria and provided written informed consent were
randomized by a research nurse, who then opened a sealed, sequentially numbered opaque
envelope. Due to the nature of the trial, blinding was not possible. However, the clinical staff
managing did not know which patients had been allocated to the conventional information
group.
Outcomes
The primary endpoint of the trial was defined as the frequency of the composite outcome of
additional healthcare visits and rehospitalizations within 30 days of hospital discharge. This
variable included a) visits to a primary care centre because of questions or complications
related to CAP (scheduled follow-up visits were excluded), b) emergency department visits for
any reason, and c) hospital readmission for any reason. Secondary outcomes included the time
to return to activities of daily living, degree of satisfaction with the information received, and
the achievement of the educational program’s goals (i.e., patient fluid intake, adherence to drug
The EDUCAP Randomized Controlled Trial
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therapy and preventive vaccines, knowledge and management of the disease, progressive adap-
tive physical activity, and alcohol and smoking cessation).
Educational Program, Follow-up and Outcomes Assessment
The individualized educational program was performed according to the Precede-Proceed
model for assessing patient health needs and developing discharge planning. This model pro-
vides a comprehensive structure for assessing health and quality of life needs, and for design-
ing, implementing, and evaluating health promotion and other public health programs aimed
to meet those needs [18]. The individualized educational program was created by the nurses
and physicians of the trial coordination team. Two research nurses were trained to deliver the
individualized educational program and provide additional educational material. They deliv-
ered the individualized educational program to the intervention group in each hospital during
patient admission. Patients received the educational program between 24h-72h before hospital
discharge, over two sessions of approximately 30 minutes each, and also received a patient edu-
cation handout about the self-management of CAP. Patients were accompanied by family
members and/or caregivers during the educational program. These two sessions were individu-
alized to needs of each patient to have adequate fluid intake, adhere to drug therapy and pre-
ventive vaccines, optimize knowledge and management of the disease, use progressive adaptive
physical activity, and alcohol and smoking cessation, if required. The interventions in the indi-
vidualized educational program are fully detailed in an appendix (S2 File).
The control group received conventional information before hospital discharge based on
the standard practices of the participating nurses and physicians. The information was not
standardized. However, it typically included details about special care needs to be followed at
home, information about drug treatment, counseling about smoking and alcohol cessation,
and information about healthcare visits. Nurses and physicians also provided this information
through the hospital discharge report.
Patients were seen daily by their attending physicians and by at least one of the investigators
during their hospital stay. The investigators assessed and recorded all primary and secondary
outcome measures. Data collection was conducted at three time points: during hospitalization,
at 30 days after discharge, and at 90 days after discharge.
The primary outcome was assessed by searching for hospital readmissions in the electronic
health records system (Systems, Applications & Products -SAP-, Waldorf, Germany) of the
Catalan Health Service at the three hospitals and confirmed either by asking patients at the
30-day follow-up visit or by telephone. The province of Barcelona (IDIBELL–Hospital Univer-
sitari de Bellvitge and the IDIBAPS–Hospital Clínic de Barcelona) and Lleida (IRBLleida–Hos-
pital Universitari Arnau de Vilanova) provides universal health coverage for 5.8 million people
[19]. All beneficiaries seen at hospitals in the Catalan Health Service are registered in the SAP,
with a unique lifetime personal health number. Data about all hospitalizations and primary
care centre or emergency department visits were routinely collected by a research nurse at each
centre using a standard protocol, and the process was supervised by the coordination team,
which included a qualified infectious diseases physician, who recorded clinical data in a com-
puter-assisted protocol.
The data for secondary outcomes were collected as follows. Time to return to normal activi-
ties of daily living was obtained by telephone consultation enquiring about time off work (total
number of days lost due to sickness absence) and the Barthel scale 90 days after discharge [20].
Patient satisfaction with the information received was evaluated 30 days after hospital dis-
charge via the question “Are you satisfied with the healthcare information regarding CAP
received at discharge?” Responses were recorded on a scale of 1 to 5, from “very unsatisfactory”
The EDUCAP Randomized Controlled Trial
PLOS ONE | DOI:10.1371/journal.pone.0140202 October 13, 2015 4 / 12
to “very satisfactory.” Patients were considered satisfied with the information received if the
response recorded was 4 or 5. To evaluate the efficacy of the education programs, we assessed
patients whether the specific objectives had been achieved prior to discharge, 30 days after dis-
charge (by telephone or at a follow-up visit), and 90 days after discharge (by telephone) using
validated scales and questionnaires. Patient fluid intake was evaluated by asking daily water
intake. We evaluated drug therapy and preventive vaccine adherence with the Haynes-Sackett
test and by checking vaccination histories. Knowledge and management of the disease was
evaluated through a CAP knowledge test which was made for the study to assess patient knowl-
edge about the symptoms and complications that can occur. Details of progressive adaptive
physical activity were collected by the average daily time walking. Finally, the level of alcohol
and smoking cessation or reduction was assessed three months after hospital discharge.
Other clinical and demographic variables were collected by daily monitoring of the patient
during hospitalization. Illness severity at presentation was measured using the CURB-65 sever-
ity score [21]. Clinical stability and the Charlson comorbidity index were used as described
elsewhere [22,23]. All assessments were obtained by a research nurse using a standard protocol
with a checklist of items.
Microbiological Analysis
Samples were obtained according to a standard protocol, and consisted of two sets of blood cul-
tures, a sputum sample when available, urine for antigen detection, and paired acute and con-
valescent serum samples [24]. Streptococcus pneumoniae antigen was detected in the urine
using a rapid immunochromatographic assay (BinaxNOW; Binax Inc). Legionella pneumophila
serogroup 1 antigen was detected in the urine using an enzyme-linked immunosorbent assay
(Bartels ELISA, Trinity Biotech). Serological studies were performed by standard methods to
determine antibodies against atypical agents.
Statistical Analysis
Sample size was calculated using the results of a Spanish cohort study of patients admitted with
CAP between 2007 and 2009 in IDIBELL (Hospital Universitari de Bellvitge), in which the rate
of additional healthcare visits and rehospitalizations was documented as 34.1% [6]. We esti-
mated that a total sample size of 204 patients was needed to detect a 50% reduction in addi-
tional healthcare visits and rehospitalizations between the two treatment groups, with an 80%
of power and a 5% significance level using the chi-squared bilateral test.
Clinical trial data was summarized using descriptive statistics. Continuous variables were
presented as number, mean, standard deviation, range, and median; categorical data, as fre-
quency counts and percentage of subjects per category. We also provided the 95% confidence
intervals (CIs) if appropriate.
We compared the primary and secondary outcomes in the two groups. For categorical vari-
ables, we performed bivariate analyses using the chi-squared or the Fisher exact tests. For quan-
titative variables, we performed the Mann–Whitney U or the Student t test depending on the
results of the Kolmogorov–Smirnov test for normality. Percentage differences of the outcomes
and mean differences between the two groups, with corresponding 95% confidence intervals,
were also computed and presented. Data for the primary and secondary end points were ana-
lyzed on an intention-to-treat and per-protocol basis. The intention-to-treat analysis included
all randomly assigned patients. Statistical analysis was performed using version 18.0 of the
SPSS software package (SPSS Inc., Chicago, Illinois). Statistical significance was established at
an α value of 0.05. All reported P values were based on two-tailed tests.
The EDUCAP Randomized Controlled Trial
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This study was registered as an International Standard Randomized Controlled Trial, num-
ber ISRCTN39531840.
Results
We assessed 327 consecutive patients for eligibility, of whom 120 were excluded (Fig 1). A total
of 207 patients were randomly assigned and included in an intention-to-treat analysis for the
primary and secondary end points. Of these, 102 were assigned to receive the individualized
educational program and 105 to receive conventional information. Two participants in each
group had alternative diagnoses to CAP after enrollment.
The baseline characteristics of the patients in the two treatment groups were similar
(Table 1). No significant differences were found regarding caregiver support at home and the
CURB-65 severity score. Complications during hospitalization and rates of intensive care unit
admission were similar between the groups. In addition, no significant differences existed
between the groups regarding stability at hospital discharge and length of hospitalization. Oth-
erwise, patients in the group receiving conventional information more often were 70 years
old and had none or primary education level (p0.05).
Etiological diagnosis was established in 44 of the 100 patients (44%) receiving individualized
education and in 49 of the 103 patients (47.6%) receiving conventional information, excluding
patients without pneumonia. The distribution of causative organisms was not different
between groups. Streptococcus pneumoniae (19 patients receiving individualized education and
31 receiving conventional information) and Haemophilus influenzae (7 and 4 patients, respec-
tively) were the most frequently isolated pathogens, followed by Influenza A (4 and 3 patients,
respectively).
Table 2 details the outcomes for study patients. In the intention-to-treat analysis, the com-
posite outcome of additional healthcare visits and rehospitalization within 30 days of hospital
discharge was 23.5% following the individualized educational program and 42.9% following
conventional information (difference, -19.4%; 95% CI, -6.5% to -31.2%; p = 0.003) (Table 2).
Similar results were obtained in the per-protocol analysis.
Compared with the group that received the individualized educational program, the group
that received conventional information had more frequent primary care centre visits (12.7% vs
27.6% [difference, -14.9%; 95% CI, -3.9% to -25.4%; p = 0.009]), emergency department visits
(10.8% vs 25.7% [difference, -14.9%; 95% CI, -4.4% to -25.2%; p = 0.007]) and rehospitaliza-
tions (4.9% vs 17.1% [difference, -12.2%; 95% CI, -3.7% to -21%; p = 0.007]), within 30 days of
hospital discharge. One patient who received conventional information died within 30 days
after hospital discharge.
Regarding the secondary end points, the time to return to activities of daily living was simi-
lar in the two groups. The median (interquartile range) of the Barthel scale 90 days after hospi-
tal discharge was higher in the group receiving individualized education than in the group
receiving conventional information, as was patient satisfaction with the information regarding
CAP received. In addition, we found a difference in the achievement of the educational pro-
gram objectives between the groups. Patient fluid intake, knowledge and management of the
disease, and progressive adaptive physical activity were higher among those receiving individu-
alized education than among those receiving conventional information. No significant differ-
ences were found in adherence to drug therapy, influenza and pneumococcal vaccination
uptake, and alcohol cessation rates. However, smoke cessation 90 days after hospital discharge
was more frequent in the group that received individualized education (50% vs 23.1% [differ-
ence, 26.9%; 95% CI, 1.5% to 47.6%; p = 0.05]).
The EDUCAP Randomized Controlled Trial
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A post hoc analysis of patients aged 70-years or older was performed. The composite out-
come of additional healthcare visits and rehospitalization within 30 days of hospital discharge
was 26.8% following the individualized educational program and 47.5% following conventional
Fig 1. Flowchart of the trial.
doi:10.1371/journal.pone.0140202.g001
The EDUCAP Randomized Controlled Trial
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information (difference, -20.7%; 95% CI, -26.8% to -47.5%; p = 0.04). Compared with the
group that received the individualized educational program, the group that received conven-
tional information had more frequent emergency department visits within 30 days of hospital
discharge (4% vs 16% [difference, -16.5%; 95% CI, -9.8% to -26.2%; p = 0.045]). However, no
differences were found regarding primary care centre visits and rehospitalizations within 30
days of hospital discharge in this group.
Table 1. Baseline characteristics. Abbreviations: CAP, community-acquired pneumonia; ICU, intensive
care unit; IQR, interquartile range; CURB-65 (confusion, urea > 7 mmol/l, respiratory rate 30/min, low sys-
tolic [<90 mm hg] or diastolic [60 mm hg] blood pressure, age 65 years).
Individual
educational
program group
Conventional
information group
N = 102 N = 105
Characteristic No. (%) No. (%)
Male sex 65 (61.9) 59 (57.8)
Age, median (IQR), yearsa 65 (50–77) 72 (59–78)
Age group, years
21–49 25 (24.5) 17 (16.2)
50–69 36 (35.3) 27 (25.7)
70–97a 41 (40.2) 61 (58.1)
Education level
None or primary-educationa 58 (56.9) 75 (71.4)
Secondary-education 24 (23.5) 16 (15.2)
Higher-education 12 (11.8) 9 (8.6)
University-education 8 (7.8) 5 (4.8)
Caregiver support home 3 (2.9) 4 (3.8)
Current smoker 31 (30.4) 26 (24.8)
Current drinker 5 (4.9) 7 (6.7)
Inﬂuenza vaccination (<1 year) 41 (40.2) 52 (49.5)
Pneumococcal vaccination (<5 years) 14 (13.7) 19 (18.1)
Previous CAP (<1 year) 10 (9.8) 13 (12.4)
Hospitalization within previous 90 days 15 (14.7) 19 (18.1)
Charlson comorbidity index, median (IQR)a 2.5 (0–5) 4 (2–6)
CURB-65, median (IQR) 2 (0.8–2) 1 (1–2)
CURB-65 0–1 points 55 (53.9) 47 (44.8)
CURB-65 2 points 34 (33.3) 37 (35.2)
CURB-65  3 points 13 (12.7) 21 (20)
Complications during hospitalizationb 45 (44.1) 34 (32.4)
ICU admission 12 (11.8) 9 (8.6)
Stable on hospital dischargec 93 (91.2) 96 (91.4)
Length of hospital stay (days), median (IQR) 6.5 (4–10) 7 (4–10.5)
a P Values0.05.
b Related to the pneumonia disease.
c Clinical stability was deﬁned as Halm.
doi:10.1371/journal.pone.0140202.t001
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Discussion
In the EDUCAP randomized trial, we assessed an individualized educational program for hos-
pitalized patients with CAP that focused on improving patient fluid intake, adherence to drug
therapy and preventive vaccines, knowledge and management of the disease, progressive adap-
tive physical activity, and counseling for alcohol and smoking cessation. Importantly, we found
that this educational program decreased the frequency of healthcare visits and rehospitaliza-
tions within 30 days of discharge.
Some studies have concluded that strategies to reduce the length of hospitalization, as well
as the trend toward community-based treatment, of patients with CAP should be accompanied
by an increased emphasis on the information and support required by patients when returning
home [14,15,17]. In addition, it has been documented that hospitalization for CAP is associated
with more healthcare interactions after hospital discharge and higher long-term mortality
Table 2. Outcomes for study patients by treatment group. Abbreviations: IQR, interquartile range.
Individual
educational program
group
Conventional
information group
n = 102 n = 105 Difference p Valueb
Characteristic No. (%) No. (%) (95% CI)a
Primary end point
Additional healthcare visits and rehospitalization 24 (23.5) 45 (42.9) -19.4 (-6.5 to -31.2) 0.003
Visits to a primary care centre 13 (12.7) 29 (27.6) -14.9 (-3.9 to -25.4) 0.009
Emergency department visits 11 (10.8) 27 (25.7) -14.9 (-4.4 to -25.2) 0.007
Rehospitalization 5 (4.9) 18 (17.1) -12.2 (-3.7 to -21) 0.007
Secondary end point
Time to return to activities of daily living
Time off work (days), median (IQR) 30 (15–66.5) 26 (12.5–37) 4 (59.5 to 68.2) 0.48
Barthel scale, median (IQR) 100 (100–100) 100 (90–100) 0 (97.5 to 93.6) 0.03
Patient satisﬁed 84 (82.4) 19 (18.4) 64 (51.5 to 73.6) <0.001
Objectives of educational program
Proper ﬂuid intakec 97 (95.1) 53 (50.5) 44.6 (33.5 to 54.4) <0.001
Adherence to drug therapyd 98 (96.1) 101 (92.2) -3.9 (-6.3 to 5.9) 1
Inﬂuenza vaccinatione 9 (8.8) 6 (5.8) 3 (-4.3 to 10.8) 0.44
Pneumococcal vaccinatione 11 (10.8) 8 (7.8) 3 (-4.9 to 11.5) 0.48
Knowledge and management of the diseasef 100 (98) 21 (20.2) 77.8 (68.1 to 84.7) <0.001
Progressive adaptive physical activityg 82 (80.4) 60 (57.1) 23.3 (10.1 to 34.8) <0.001
Smoke cessation 15 (50) 6 (23.1) 26.9 (1.5 to 47.6) 0.05
Smoke reduction 23 (76.7) 8 (30.8) 45.9 (19.8 to 64.2) 0.001
Alcohol cessation 2 (40) 1 (14.3) 25.7 (-20.8 to 64.5) 0.52
Alcohol reduction 2 (40) 1 (14.3) 25.7 (-20.8 to 64.5) 0.52
a Values are percentage points for categorical variables.
b Categorical variables were compared using the Fisher exact test and continuous variable using the Mann-Whitney U test.
c Proper ﬂuid intake includes patients who drink at least 1,5 liters daily.
d Patients were stratiﬁed into good adherence to drug therapy according to the Haynes-Sackett test (80–110% of treatment adherence).
e Inﬂuenza and pneumococcal vaccination were evaluated three months after discharge.
f Knowledge and management of the disease was evaluated through CAP knowledge test (sufﬁcient or excellent knowledge).
g Progressive adaptive physical activity was collected by the time walking away schedule (15–30 daily minutes).
doi:10.1371/journal.pone.0140202.t002
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compared with other major medical conditions [6,7,25–28]. Therefore, some investigators
have recommended that new educational interventions are needed to improved patient under-
standing of their post-discharge care. These interventions could have important economic ben-
efits by encouraging cost-effective health service use. Discharge planning has been associated
with improved referral to and utilization of post-discharge services, and also with fewer read-
missions. Furthermore, such planning appears to prepare patients and caregivers for post-dis-
charge care [13].
Few studies have evaluated the efficacy of educational interventions in patients with CAP.
In the studies undertaken to date, the results are mixed. Some studies support the usefulness of
such programs in improving patient understanding of post-discharge care [14,15], but others
do not [16]. For example, investigators designed interventions to improve patient knowledge
that aimed to reduce the time from clinical stability to the switch to oral antibiotics. Patient
education included explaining that it takes time to recover from pneumonia, recommending
that medications be taken as prescribed, that patient eat healthy foods, and that they monitor
for warning signs. Patients were satisfied that they received the information which needed to
recover, and most reported that they were of the danger signs of relapse [14]. In the present
study, the individualized educational program results in a significant decrease in additional
healthcare visits and rehospitalizations within 30-days of hospital discharge.
The group that received the individualized educational program achieved more of the edu-
cational objectives. Patient fluid intake, knowledge and management of the disease, progressive
adaptive physical activity, and smoking cessation were higher, although no differences were
found in adherence to drug therapy, influenza and pneumococcal vaccination uptake, and alco-
hol cessation. Our findings are consistent with the findings of previous reports that educational
interventions improved patient experiences, increased their understanding of post-discharge
care, and increases the level of patient satisfaction [14,15]. Moreover, our results may help to
developed a new model of in-hospital smoking cessation intervention as suggested in a recent
review [29].
The strengths of this study are that it is the first randomized, controlled clinical trial with an
intervention arm that received individualized patient education according to the Precede–Pro-
ceed model [18]. In addition, a large number of patients were included and just one patient
who died was lost of 30-day follow-up visit. Nevertheless, there were no missing data on pri-
mary and secondary outcomes. However, some limitations should be acknowledged. First,
patients receiving conventional information tended to be older and with low educational level;
however, when we restricted the analysis to patients aged 70-years or older and none or pri-
mary-education we obtained similar results. In patients aged 70-years or older, the individual-
ized educational program results only have a significant decrease in emergency department
visits within 30 days of hospital discharge. Our finding concurs with previous reports that
patient education could optimize the use of post-discharge services in patients with CAP
[6,15]. Second, information about additional healthcare visits and rehospitalizations within 30
days of discharge were obtained by reviewing the Catalan Health Services database and checked
by asking patients or family members at the final outpatient visit or by telephone. Therefore,
patients or relatives might not have remembered some visits to private primary care centre or
hospitals. Third, we did not evaluate the long-term mortality after hospital discharge in our
study. Future studies, may need to assess the effect of individualized educational program on
long-term mortality. Finally, it should be emphasized that the EDUCAP trial was not blinded.
In summary, the implementation of an individualized educational program for hospitalized
patients with CAP was effective in reducing subsequent healthcare visits and rehospitalizations
within 30 days of discharge. Such a strategy may help optimize available healthcare resources
and identify post-acute care needs in patients with CAP.
The EDUCAP Randomized Controlled Trial
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